After active treatment, the success rate of anti-cancer for stomach cancer of different stages varies, and the five-year survival period can be between 10% and 90%. Gastric cancer is a common malignant tumor of digestive system. Clinically, it is often divided into four stages according to the development of gastric cancer, the degree of lymph node metastasis and whether there is distant metastasis, and the cure rate is different in different periods. After active treatment, the five-year survival period of Stage I gastric cancer patients is about 85%~90%; Stage II is about 65%~70%; Stage III is 30%~50%; and Stage IV is about 10%. Clinical five-year survival is often used as an indicator of tumor cure, which is equivalent to the success rate of anti-cancer. After surgery, patients should pay attention to regular review and maintain good living habits, which can prolong the survival period and improve the success rate of anti-cancer.